These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Neoadjuvant treatment of a solitary melanoma brain metastasis with vemurafenib. Kolar GR; Miller-Thomas MM; Schmidt RE; Simpson JR; Rich KM; Linette GP J Clin Oncol; 2013 Jan; 31(3):e40-3. PubMed ID: 23233711 [No Abstract] [Full Text] [Related]
25. Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome. Panagiotou IE; Brountzos EN; Kelekis DA; Papathanasiou MA; Bafaloukos DI Neoplasma; 2005; 52(2):150-8. PubMed ID: 15800714 [TBL] [Abstract][Full Text] [Related]
26. [Treatment of patients with brain metastases from a melanoma]. Modesto A; Chira C; Sol JC; Lubrano V; Boulinguez S; Pagès C; Sibaud V; Gomez-Roca C; Moyal É; Meyer N Cancer Radiother; 2019 Apr; 23(2):147-150. PubMed ID: 30904418 [TBL] [Abstract][Full Text] [Related]
27. Radiosurgery/stereotactic radiotherapy in combination with immunotherapy and targeted agents for melanoma brain metastases. Trino E; Mantovani C; Badellino S; Ricardi U; Filippi AR Expert Rev Anticancer Ther; 2017 Apr; 17(4):347-356. PubMed ID: 28277101 [TBL] [Abstract][Full Text] [Related]
28. The treatment of brain metastases from malignant melanoma. Douglas JG; Margolin K Semin Oncol; 2002 Oct; 29(5):518-24. PubMed ID: 12407517 [TBL] [Abstract][Full Text] [Related]
29. Impressive regression of visceral and cerebral melanoma metastases under combination treatment including dacarbacine, radiotherapy and celecoxib. Becker MR; Gaiser T Int J Dermatol; 2009 Feb; 48(2):207-9. PubMed ID: 19200209 [No Abstract] [Full Text] [Related]
30. Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. Hofmann M; Kiecker F; Wurm R; Schlenger L; Budach V; Sterry W; Trefzer U J Neurooncol; 2006 Jan; 76(1):59-64. PubMed ID: 16132502 [TBL] [Abstract][Full Text] [Related]
31. Temozolomide as prophylaxis for melanoma brain metastases. Conill C; González-Cao M; Jorcano S; Puig S; Malvehy J; Martí R; Castel T Melanoma Res; 2004 Feb; 14(1):73-4. PubMed ID: 15091198 [No Abstract] [Full Text] [Related]
32. Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial. Weber JS; Amin A; Minor D; Siegel J; Berman D; O'Day SJ Melanoma Res; 2011 Dec; 21(6):530-4. PubMed ID: 22051508 [TBL] [Abstract][Full Text] [Related]
33. Checkpoint inhibitors in the treatment of brain metastases of non-small-cell lung cancer and melanoma. Kourie HR; Kanaan H; Awada G; Awada AH Future Oncol; 2017 May; 13(12):1097-1103. PubMed ID: 28326837 [TBL] [Abstract][Full Text] [Related]
34. Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies. Sloot S; Chen YA; Zhao X; Weber JL; Benedict JJ; Mulé JJ; Smalley KS; Weber JS; Zager JS; Forsyth PA; Sondak VK; Gibney GT Cancer; 2018 Jan; 124(2):297-305. PubMed ID: 29023643 [TBL] [Abstract][Full Text] [Related]
35. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial. Margolin K; Ernstoff MS; Hamid O; Lawrence D; McDermott D; Puzanov I; Wolchok JD; Clark JI; Sznol M; Logan TF; Richards J; Michener T; Balogh A; Heller KN; Hodi FS Lancet Oncol; 2012 May; 13(5):459-65. PubMed ID: 22456429 [TBL] [Abstract][Full Text] [Related]
36. Melanoma in the brain: biology and therapeutic options. Gibney GT; Forsyth PA; Sondak VK Melanoma Res; 2012 Jun; 22(3):177-83. PubMed ID: 22495668 [TBL] [Abstract][Full Text] [Related]
37. Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases. Patel KR; Shoukat S; Oliver DE; Chowdhary M; Rizzo M; Lawson DH; Khosa F; Liu Y; Khan MK Am J Clin Oncol; 2017 Oct; 40(5):444-450. PubMed ID: 26017484 [TBL] [Abstract][Full Text] [Related]
38. Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part II: Management of stage IV disease. Fox MC; Lao CD; Schwartz JL; Frohm ML; Bichakjian CK; Johnson TM J Am Acad Dermatol; 2013 Jan; 68(1):13.e1-13; quiz 26-8. PubMed ID: 23244384 [TBL] [Abstract][Full Text] [Related]